Lenneke Am Cornelissen

6PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 11, 2026
Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration.

|Apr 03, 2026
Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity.

Jesper van Eck van der Sluijs, Anne H C Valk, Eline J H van Houtum

|Jan 22, 2025
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages.

Lisa Gm Huis In 't Veld, Lenneke Am Cornelissen, Lune van den Bogaard

|Sep 09, 2024
Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling.

Eline Jh van Houtum, Anne Hc Valk, Daniel Granado

|Jul 27, 2024
Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid Cells.

Lenneke A M Cornelissen, Kim C M Santegoets, Esther D Kers-Rebel

|May 30, 2023
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7.

Eline J H van Houtum, Esther D Kers-Rebel, Maaike W Looman

Pageof 1

Frequent Collaborators

5 joint publications

Gosse J Adema

3 joint publications

Eline Jh van Houtum

3 joint publications

Lune van den Boogaard

2 joint publications

Christian Büll